Çoker Gürkan, AjdaPalavan Unsal, NarçinArısan, SerdarSonmez, Nurettin CemARISAN, ELİF DAMLA2018-07-112018-07-1120130042-1138https://doi.org/10.1159/000345786https://hdl.handle.net/11413/2013Urolithiasis is a common multifactorial urological disorder that is characterized by stone formation. Interleukin (IL)-1 and IL-6 are pro-inflammatory cytokines that might be linked with urolithiasis. The single nucleotide polymorphisms within the IL-1 and IL-6 cytokine genes altered the cytokine expression levels. Our aim was to investigate the potential of IL-1 beta (-511 C>T), IL-6 (-174 G>C, 572 G>C, 597 G>A) and IL-1 RN VNTR gene polymorphisms to be a genetic marker for urinary stone disease. The polymorphisms studied in the promoter regions of IL-1 beta and IL-6 genes did not reveal a strong association with urolithiasis when compared to the control group (p = 0.293, 0.871, 0.921, 0.536, respectively). However, a significant difference was observed between control and patient groups for IL-1 RN VNTR gene polymorphism (chi(2) = 6.131, d.f. = 2, p = 0.047). Our data provide evidence that IL-1RN VNTR gene polymorphism may be involved in the pathogenesis of urinary stone formation, contributing to genetic susceptibility for urolithiasis. (C) 2013 S. Karger AG, Baselen-USUrolithiasisInterleukin-1Interleukin-6Single nucleotide polymorphismReceptor Antagonist GeneCalcium-Oxalate StonesVitamin-D-ReceptorKidney-StonesInterleukin-1-Beta GeneTandem RepeatNephrolithiasisExcretionIntron-2ProteinArticle3238631000163238631000162336355923363559